Instantly screen for COVID-19 using only a smartphone
- https://www.resapphealth.com.au/covid-19/
ResApp is developing the world’s first COVID-19 instant screening test that will use cough sounds to indicate the presence of a COVID-19 infection.
ResApp has previously developed the only regulatory approved diagnostic for respiratory disease using cough sounds analysed on a smartphone.
This experience uniquely positions the company to deliver an instant screening test for COVID-19 and its variants that will have applications for consumers, businesses and governments globally.By using its large dataset of clinically-labelled non-COVID-19 cough samples, including coughs from patients with non-COVID-19 lower respiratory tract infections, ResApp will be able to ensure that any COVID-19 screening test developed accurately identifies COVID-19 and not other respiratory diseases.
ResApp has three clinical trials currently recruiting patients in the United States and India to collect cough sounds, symptoms and validated COVID-19 status through PCR testing. These studies will generate the high quality data, backed by accurate ground truth labelling through PCR testing, that is needed to train a robust machine learning algorithm. The studies are also collecting PCR test cycle thresholds, allowing evaluation of algorithm sensitivity to viral load.
- Forums
- ASX - By Stock
- RAP
- COVID-19 Instant Screening test
COVID-19 Instant Screening test
-
-
- There are more pages in this discussion • 1,021 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online